Sequential trial with B method of Potvin [Two-Stage / GS Designs]

posted by john john – Spain, 2015-10-01 19:44 (3907 d 08:18 ago) – Posting: # 15513
Views: 16,245

In a sequential clinical trial conducted like a B method of Potvin, we have Cmax and AUC both not bioequivalent. Cmax has a power <80% (71.5%), and AUC>80% (84.6%).
AUC 0-30min calculated by protocol is bioequivalent.
In the protocol it was not specified how to proceed in this situation.

Can we calculate a new n and pass to the second phase? Or we must stop the trial?

Thanks


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
128 visitors (0 registered, 128 guests [including 28 identified bots]).
Forum time: 04:02 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5